Cargando…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from th...
Autores principales: | Lai, Chih-Cheng, Shih, Tzu-Ping, Ko, Wen-Chien, Tang, Hung-Jen, Hsueh, Po-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127800/ https://www.ncbi.nlm.nih.gov/pubmed/32081636 http://dx.doi.org/10.1016/j.ijantimicag.2020.105924 |
Ejemplares similares
-
The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis
por: Lai, Chih-Cheng, et al.
Publicado: (2021) -
In vitro diagnostics of coronavirus disease 2019: Technologies and application
por: Lai, Chih-Cheng, et al.
Publicado: (2021) -
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
por: Lai, Chih-Cheng, et al.
Publicado: (2020) -
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials
por: Lai, Chih-Cheng, et al.
Publicado: (2021) -
Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status
por: Lai, Chih-Cheng, et al.
Publicado: (2020)